+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Antidepressants increase β-arrestin 2 ubiquitinylation and degradation by the proteasomal pathway in C6 rat glioma cells



Antidepressants increase β-arrestin 2 ubiquitinylation and degradation by the proteasomal pathway in C6 rat glioma cells



Journal of Pharmacology and Experimental Therapeutics 332(3): 970-976



beta-Arrestins, regulators of G protein-coupled receptor-G protein coupling and receptor desensitization and internalization, function also as scaffolding proteins mediating cellular signaling events. beta-Arrestin1 was previously implicated by us in the pathophysiology of depression and in the mechanism of action of antidepressants (ADs). The ubiquitously expressed beta-arrestins1 and 2 are structurally highly homologous. There has been extensive investigation of these two proteins to determine whether they serve different roles in receptor signaling. In this study, we show that treatment of C(6) rat glioma cells with ADs of various types for 3 days resulted in decreased beta-arrestin2 levels. In contrast, beta-arrestin2 mRNA expression was found to be up-regulated by ADs. To unravel the mechanism for these opposite effects several possible beta-arrestin2 post-transcriptional events and modifications were examined. C(6) rat glioma cells transfected with beta-arrestin1-targeted short hairpin RNA showed similar effects of ADs on beta-arrestin2 levels. AD-induced decreases in beta-arrestin2 protein levels were not due to cytosolic membrane translocation. Immunoprecipitation experiments showed that ADs were able to increase coimmunoprecipitation of ubiquitin with beta-arrestin2. AD-induced increases in beta-arrestin2 ubiquitinylation led to its degradation by the proteasomal pathway, as the proteasome inhibitor N-[(phenylmethoxy)carbonyl]-l-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-l-leucinamide (MG-132) prevented antidepressant-induced decreases in beta-arrestin2 protein levels.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 051580122

Download citation: RISBibTeXText

PMID: 19996297

DOI: 10.1124/jpet.109.160218


Related references

Phorbol esters induce intracellular accumulation of the anti-apoptotic protein PED/PEA-15 by preventing ubiquitinylation and proteasomal degradation. Journal of Biological Chemistry 282(12): 8648-8657, 2007

Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. Journal of Biological Chemistry 282(12): 9082-9089, 2007

TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin. Neuroscience Letters 442(2): 109-113, 2008

The flavonoid kaempferol sensitizes human glioma cells to TRAIL-mediated apoptosis by proteasomal degradation of survivin. Molecular Cancer Therapeutics 7(11): 3566-3574, 2008

Genistein enhances proteasomal degradation of the short isoform of FLIP in malignant glioma cells and thereby augments TRAIL-mediated apoptosis. Neuroscience Letters 453(2): 92-97, 2009

A combination of Trastuzumab and 17-AAG induces enhanced ubiquitinylation and lysosomal pathway-dependent ErbB2 degradation and cytotoxicity in ErbB2-overexpressing breast cancer cells. Cancer Biology and Therapy 7(10): 1630-1640, 2008

Tu1400 Angiotensin Ii Decreases P-Glycoprotein in Intestinal Epithelial Cells via a Proteasomal Degradation Pathway. Gastroenterology 148(4): S-879, 2015

Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. Febs Letters 587(10): 1571-1578, 2013

A potent betulinic acid analogue ascertains an antagonistic mechanism between autophagy and proteasomal degradation pathway in HT-29 cells. Bmc Cancer 16: 23, 2016

Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway. Journal of Carcinogenesis and Mutagenesis Suppl 6: 005, 2013

Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway. International Journal of Neuropsychopharmacology 14(10): 1289-1300, 2011

Disproportionately high levels of HGF induce the degradation of the c-met receptor through the proteasomal degradation pathway. Biochemical and Biophysical Research Communications 505(3): 925-930, 2018

The MAPK pathway directs the proteasomal degradation of Inducible cAMP Early Repressor during the cell cycle of prostate cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 548, 2002

12-O-tetradecanoylphorbol-1,3-acetate-induced degradation of protein kinase B via ubiquitin-proteasomal pathway depends on its Ser473 phosphorylation in gastric cancer cells. Folia Histochemica et Cytobiologica 51(1): 11-17, 2013

12-O-tetradecanoylphorbol-1,3-acetate-induced degradation of protein kinase B via ubiquitin- -proteasomal pathway depends on its Ser473 phosphorylation in gastric cancer cells. 2013